Oral Pyridoxine during Pregnancy
Authors:
- 1 January 2004
- journal article
- Published by Springer Nature in Drugs in R&D
- Vol. 5 (5) , 259-269
Abstract
Objective: To study the human risk and benefit of oral pyridoxine (vitamin B6) treatment during pregnancy. Design and setting: The analysis of cases with 25 congenital abnormality (CA) groups and their all-matched controls without CAs in the population-based dataset of the large Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Study participants: 22 843 cases of pregnant women who had newborns or fetuses with CAs and 38 151 pregnant women who had newborn infants without any CAs (control group). Main outcome measures: Prevalence of pyridoxine use in early pregnancy among mothers of cases with different CAs and control mothers with infants without any CA. Results: 2013 (8.8%) case mothers and 4086 (10.7%) control mothers were treated with pyridoxine (adjusted prevalence odds ratio [POR] 0.8; 95% confidence interval [CI] 0.7, 0.9). The analysis of cases with different defects and their all-matched controls did not indicate any obvious teratogenic potential of pyridoxine use during the second and third months of gestation, i.e. in the critical period for the development of most major CAs. However, some protective effect was found for cardiovascular malformations (adjusted POR 0.8; 95% CI 0.7, 0.9). Conclusion: Treatment with pyridoxine during pregnancy does not indicate a teratogenic risk to the fetus, but may provide some protective effect for cardiovascular malformations.Keywords
This publication has 39 references indexed in Scilit:
- The first trimester concept is outdatedCongenital Anomalies, 2001
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Pharmacological Agents Affecting EmesisDrugs, 1992
- Pharmacological Agents Affecting EmesisDrugs, 1992
- Further studies on protective effects of vitamins in cyclophosphamide-induced cleft palateInternational Journal of Oral and Maxillofacial Surgery, 1990
- PHOCOMELIA IN INFANT WHOSE MOTHER TOOK LARGE DOSES OF PYRIDOXINE DURING PREGNANCYThe Lancet, 1985
- Reversal of Psychopathology in Adult Coeliac Disease with the Aid of Pyridoxine (Vitamin B6)Scandinavian Journal of Gastroenterology, 1983
- Vitamin B6 reduces cortisone‐induced cleft palate in the mouseTeratology, 1982
- Teratogenicity study in rats given high doses of pyridoxine (vitamin B6) during organogenesisCellular and Molecular Life Sciences, 1975
- Cleft palate formation: A role for pyridoxine in the closure of the secondary palate in miceTeratology, 1972